Malignant Pleural Effusions are a serious complication of advanced cancer. Fluid builds up in the space between the lung and chest wall compressing the lung and thoracic structures. This frequently results in disabling shortness of breath and poor quality of life.
Malignant Pleural Effusions affect about 200,000 patients every year in the US. Unfortunately, current therapies are not always effective, and can require an invasive procedure or are cumbersome to manage.
TDLI has developed an improved delivery system. This novel approach improves treatment by making it easier for the patient to receive appropriate therapy.